BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 31783872)

  • 1. Correction to: c-Src confers resistance to mitotic stress through inhibition of DMAP1/Bub3 complex formation in pancreatic cancer.
    Li J; Hu B; Wang T; Huang W; Ma C; Zhao Q; Zhuo L; Zhang T; Jiang Y
    Mol Cancer; 2019 Nov; 18(1):172. PubMed ID: 31783872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C-Src confers resistance to mitotic stress through inhibition DMAP1/Bub3 complex formation in pancreatic cancer.
    Li J; Hu B; Wang T; Huang W; Ma C; Zhao Q; Zhuo L; Zhang T; Jiang Y
    Mol Cancer; 2018 Dec; 17(1):174. PubMed ID: 30553276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BubR1 Promotes Bub3-Dependent APC/C Inhibition during Spindle Assembly Checkpoint Signaling.
    Overlack K; Bange T; Weissmann F; Faesen AC; Maffini S; Primorac I; Müller F; Peters JM; Musacchio A
    Curr Biol; 2017 Oct; 27(19):2915-2927.e7. PubMed ID: 28943088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Drosophila Bub3 protein is required for the mitotic checkpoint and for normal accumulation of cyclins during G2 and early stages of mitosis.
    Lopes CS; Sampaio P; Williams B; Goldberg M; Sunkel CE
    J Cell Sci; 2005 Jan; 118(Pt 1):187-98. PubMed ID: 15615783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of the mitotic checkpoint genes BUB1, BUBR1, and BUB3 in gastric cancer--association with tumour cell proliferation.
    Grabsch H; Takeno S; Parsons WJ; Pomjanski N; Boecking A; Gabbert HE; Mueller W
    J Pathol; 2003 May; 200(1):16-22. PubMed ID: 12692836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bub3 promotes Cdc20-dependent activation of the APC/C in S. cerevisiae.
    Yang Y; Tsuchiya D; Lacefield S
    J Cell Biol; 2015 May; 209(4):519-27. PubMed ID: 25987604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rae1 is an essential mitotic checkpoint regulator that cooperates with Bub3 to prevent chromosome missegregation.
    Babu JR; Jeganathan KB; Baker DJ; Wu X; Kang-Decker N; van Deursen JM
    J Cell Biol; 2003 Feb; 160(3):341-53. PubMed ID: 12551952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased chromosome instability but not cancer predisposition in haploinsufficient Bub3 mice.
    Kalitsis P; Fowler KJ; Griffiths B; Earle E; Chow CW; Jamsen K; Choo KH
    Genes Chromosomes Cancer; 2005 Sep; 44(1):29-36. PubMed ID: 15898111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correction to: Epigenetic regulation of L1CAM in endometrial carcinoma: comparison to cancer-testis (CT-X) antigens.
    Schirmer U; Fiegl H; Pfeifer M; Zeimet AG; Müller-Holzner E; Bode PK; Tischler V; Altevogt P
    BMC Cancer; 2018 Oct; 18(1):1047. PubMed ID: 30373551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting the yin and the yang: combined inhibition of the tyrosine kinase c-Src and the tyrosine phosphatase SHP-2 disrupts pancreatic cancer signaling and biology in vitro and tumor formation in vivo.
    Gomes EG; Connelly SF; Summy JM
    Pancreas; 2013 Jul; 42(5):795-806. PubMed ID: 23271399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel 1p tumour suppressor Dnmt1-associated protein 1 regulates MYCN/ataxia telangiectasia mutated/p53 pathway.
    Yamaguchi Y; Takenobu H; Ohira M; Nakazawa A; Yoshida S; Akita N; Shimozato O; Iwama A; Nakagawara A; Kamijo T
    Eur J Cancer; 2014 May; 50(8):1555-65. PubMed ID: 24559687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bub3 gene disruption in mice reveals essential mitotic spindle checkpoint function during early embryogenesis.
    Kalitsis P; Earle E; Fowler KJ; Choo KH
    Genes Dev; 2000 Sep; 14(18):2277-82. PubMed ID: 10995385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural analysis of Bub3 interactions in the mitotic spindle checkpoint.
    Larsen NA; Al-Bassam J; Wei RR; Harrison SC
    Proc Natl Acad Sci U S A; 2007 Jan; 104(4):1201-6. PubMed ID: 17227844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Corrigendum] miR-9 regulates the multidrug resistance of chronic myelogenous leukemia by targeting ABCB1.
    Li Y; Zhao L; Li N; Miao Y; Zhou H; Jia L
    Oncol Rep; 2019 May; 41(5):3148. PubMed ID: 30896876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correction to: CCN2 inhibits lung cancer metastasis through promoting DAPK-dependent anoikis and inducing EGFR degradation.
    Chang CC; Yang MH; Lin BR; Chen ST; Pan SH; Hsiao M; Lai TC; Lin SK; Jeng YM; Chu CY; Chen RH; Yang PC; Chin YE; Kuo ML
    Cell Death Differ; 2019 Jan; 26(1):196. PubMed ID: 30185823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C-Cbl reverses HER2-mediated tamoxifen resistance in human breast cancer cells.
    Li W; Xu L; Che X; Li H; Zhang Y; Song N; Wen T; Hou K; Yang Y; Zhou L; Xin X; Xu L; Zeng X; Shi S; Liu Y; Qu X; Teng Y
    BMC Cancer; 2018 May; 18(1):507. PubMed ID: 29720121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bub3 interaction with Mad2, Mad3 and Cdc20 is mediated by WD40 repeats and does not require intact kinetochores.
    Fraschini R; Beretta A; Sironi L; Musacchio A; Lucchini G; Piatti S
    EMBO J; 2001 Dec; 20(23):6648-59. PubMed ID: 11726501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dmap1 plays an essential role in the maintenance of genome integrity through the DNA repair process.
    Negishi M; Chiba T; Saraya A; Miyagi S; Iwama A
    Genes Cells; 2009 Nov; 14(11):1347-57. PubMed ID: 19845771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Corrigendum] Inhibition of MDA-MB-231 breast cancer cell migration and invasion activity by andrographolide via suppression of nuclear factor-κB-dependent matrix metalloproteinase-9 expression.
    Zhai Z; Qu X; Li H; Ouyang Z; Yan W; Liu G; Liu X; Fan Q; Tang T; Dai K; Qin A
    Mol Med Rep; 2019 Mar; 19(3):1979. PubMed ID: 30628678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Publisher Correction: Barcoding reveals complex clonal behavior in patient-derived xenografts of metastatic triple negative breast cancer.
    Merino D; Weber TS; Serrano A; Vaillant F; Liu K; Pal B; Di Stefano L; Schreuder J; Lin D; Chen Y; Asselin-Labat ML; Schumacher TN; Cameron D; Smyth GK; Papenfuss AT; Lindeman GJ; Visvader JE; Naik SH
    Nat Commun; 2019 Apr; 10(1):1945. PubMed ID: 31019194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.